Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ARCA Biopharma Inc ABIO

Healthcare Biotechnology
ARCA biopharma, Inc. is a clinical-stage biopharmaceutical company engaged in developing genetically and other targeted therapies for cardiovascular diseases through a precision medicine approach to drug development. The Company's lead product candidate is Gencaro (bucindolol hydrochloride) for the treatment of atrial fibrillation (AF) in patients with chronic heart failure (HF). Gencaro is... see more

Recent & Breaking News (NDAQ:ABIO)

The Daily Biotech Pulse: Opko Settles With SEC, Obalon Inks Financing Deals, Harpoon Files For IPO

Benzinga.com  December 28, 2018

The Daily Biotech Pulse: Tracon Aces Early-Stage Trials, Boston Scientific To Buy Out Millipede

Benzinga.com  December 27, 2018

The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial

Benzinga.com  December 21, 2018

ARCA biopharma Updates Special Protocol Assessment Request to FDA for Gencaro Phase 3 Atrial Fibrillation Clinical Trial

GlobeNewswire December 20, 2018

45 Stocks Moving In Thursday's Mid-Day Session

Benzinga.com  November 15, 2018

34 Stocks Moving In Thursday's Pre-Market Session

Benzinga.com  November 15, 2018

ARCA biopharma Announces Third Quarter 2018 Financial Results and Provides Corporate Update

GlobeNewswire November 14, 2018

GENETIC-AF Phase 2B Clinical Trial Atrial Fibrillation Burden (AFB) Results Presented at American Heart Association 2018 Scientific Sessions

GlobeNewswire November 12, 2018

ARCA Biopharma announces phase 2B GENETIC-AF atrial fibrillation burden (AFB) results selected for presentation at american heart association 2018 scientific sessions

GlobeNewswire November 5, 2018

ARCA biopharma Submits Special Protocol Assessment Request to FDA for Gencaro Phase 3 Atrial Fibrillation Clinical Trial

GlobeNewswire September 18, 2018

The Growing Demand for Cancer Treatment is Raising Immunotherapy Dependence

PR Newswire August 31, 2018

ARCA biopharma Announces Second Quarter 2018 Financial Results and Provides Corporate Update

GlobeNewswire August 9, 2018

ARCA Biopharma Announces Positive Outcome of End-of-Phase 2 Meeting With FDA on Gencaro Development for Atrial Fibrillation

GlobeNewswire July 31, 2018

GENETIC-AF Phase 2B Clinical Trial Results Presented in Late Breaking Presentation at European Society of Cardiology Heart Failure 2018 World Congress

GlobeNewswire May 29, 2018

ARCA biopharma Announces Phase 2B GENETIC-AF Clinical Trial Results Selected for Late Breaking Oral Presentation at European Society of Cardiology Heart Failure 2018 World Congress

GlobeNewswire May 10, 2018

ARCA Biopharma announces first quarter 2018 financial results AND Provides Corporate Update

GlobeNewswire May 8, 2018

ARCA biopharma Announces Fiscal Year 2017 Financial Results and Provides Corporate Update

GlobeNewswire March 22, 2018

The Week Ahead In Biotech: Earnings, PDUFA Dates And More

Benzinga.com  March 2, 2018

ARCA biopharma Reports Topline Phase 2B Results for GENETIC-AF Clinical Trial

GlobeNewswire February 26, 2018

ARCA biopharma Announces Completion of GENETIC-AF Phase 2B Clinical Trial

GlobeNewswire January 8, 2018